Not Yet Recruiting PHASE3 INTERVENTIONAL 2-arm
NCT06267300
Treatment of Post-COVID-19 With Hyperbaric Oxygen Therapy: a Randomized, Controlled Trial
Sponsor: Da Vinci Clinic
Conditions
Long COVID Long Covid19 Post COVID-19 Condition Post COVID-19 Condition, Unspecified Post-COVID Condition Post-COVID Syndrome Post-COVID-19 Syndrome
Interventions
Hyperbaric oxygen
Updated 3 times since 2024 Last updated: Feb 26, 2024 Started: Oct 1, 2024 Primary completion: Oct 1, 2025 Completion: Apr 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE3 trial investigates Long COVID and Long Covid19 and is currently actively recruiting participants. Da Vinci Clinic leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Not Yet Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Da Vinci Clinic
- Erasmus Medical Center
- HGC Rijswijk
Data source: Erasmus Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .